Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
ENDOCYTE
(NQ:
ECYT
)
12.88
USD
+0.18 (+1.42%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
All news about ENDOCYTE
< Previous
1
2
3
4
5
6
7
Next >
Endocyte Announces Poster Presentations on Vintafolide and Etarfolatide at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO)
May 30, 2013
from
GlobeNewswire News Releases
Endocyte to Present at the Jefferies 2013 Global Healthcare Conference
May 29, 2013
from
GlobeNewswire News Releases
Endocyte Appoints Scot L. Harper, Ph.D., as Vice President of Clinical Operations
May 07, 2013
from
GlobeNewswire News Releases
Endocyte, Inc. (ECYT) Posts Q1 Loss of 11c/Share
May 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8301176 for the full story.
Read More
from
StreetInsider.com News Articles
Endocyte Reports First Quarter 2013 Financial Results and Business Update
May 02, 2013
from
GlobeNewswire News Releases
American Real Disposable Income Collapses in First Quarter of 2013
April 30, 2013
category
Pharmaceuticals
,
Exchanges
from
Trefis
Clinical Study Shows Involvement of Activated Macrophages in Osteoarthritis, Identified by Endocyte's Etarfolatide
April 25, 2013
from
GlobeNewswire News Releases
Endocyte, Inc. Announces Annual Stockholders' Meeting
April 22, 2013
from
GlobeNewswire News Releases
Endocyte Announces First Quarter 2013 Earnings Conference Call
April 18, 2013
from
GlobeNewswire News Releases
Endocyte, Inc. (ECYT) Reports Q4 Loss of $0.10
April 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8253661 for the full story.
Read More
from
StreetInsider.com News Articles
Endocyte Announces Presentations at AACR Annual Meeting 2013
April 03, 2013
from
GlobeNewswire News Releases
Endocyte, Inc. (NASDAQ:ECYT), SINA Corporation (NASDAQ:SINA), and Sangamo Biosciences Inc. (NASDAQ:SGMO) Added to Growing Stock Report's NASDAQ Gainers Watch List.
April 02, 2013
New York, NY -- (SBWIRE) -- 04/02/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Endocyte, Inc. (NASDAQ:ECYT), SINA Corporation (NASDAQ:SINA), and Sangamo Biosciences...
Read More
from
SBWire - Latest Press Releases
Investors Alert: Endocyte, GrafTech International Ltd, Star Scientific, The McGraw-Hill Companies
April 01, 2013
Lakeway, NY -- (SBWIRE) -- 04/01/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on...
Read More
from
SBWire - Latest Press Releases
Endocyte to Present at the Future Leaders in the Biotech Industry Conference
April 01, 2013
from
GlobeNewswire News Releases
Active Stocks In The Latest Trading Session: (NYSE: EXM), (NASDAQ: ECYT)
March 29, 2013
from
ACCESSWIRE
Active Stocks in the Latest Trading Session: (NYSE:EXM), (NASDAQ:ECYT)
March 29, 2013
from
SBWire Direct - Latest Press Releases
Free Research Reports on CHTP, ECYT, MFRM and RVLT Issued by the Bedford Report
March 28, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit
Read More
from
Marketwired News Releases
Unusual 11 Mid-Day Movers 03/27: (CHCI) (UEPS) (UTSI) Higher; (ASTM) (EVBS) (CLF) Lower
March 27, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8215168 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE: Wedbush Raises PT on Endocyte on Significant Catalysts Ahead
March 27, 2013
In a report published Wednesday, Wedbush analyst Gregory R. Wade reiterated an Outperform rating on Endocyte (NASDAQ: ECYT ), and raised the price target from $16.00 to $20.00. In the report, Wade...
Read More
category
Benzinga
,
Wedbush
,
ECYT
, and 3 more.
from
Latest Articles from Benzinga.com
Wedbush Sees a Near Double in Endocyte (ECYT)
March 27, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8214414 for the full story.
Read More
from
StreetInsider.com News Articles
Array BioPharma, Inc. (NASDAQ:ARRY) and Endocyte, Inc. (NASDAQ:ECYT) Added to Growing Stock Report's NASDAQ Gainers Watch List.
March 25, 2013
New York, NY -- (SBWIRE) -- 03/25/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Array BioPharma, Inc. (NASDAQ:ARRY) and Endocyte, Inc. (NASDAQ:ECYT).
Read More
from
SBWire - Latest Press Releases
Baird Upgrades Endocyte (ECYT) to Outperform
March 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8207985 for the full story.
Read More
from
StreetInsider.com News Articles
Endocyte (ECYT) Files $125M Mixed Shelf
March 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8192938 for the full story.
Read More
from
StreetInsider.com News Articles
Endocyte to Webcast Investor and Analyst Day in New York City
March 18, 2013
from
GlobeNewswire News Releases
Endocyte's Investigational Diagnostic Imaging Agent Etarfolatide Identifies Ovarian Cancer and Non-Small Cell Lung Cancer Patients Most Likely to Benefit From Folate Receptor-Targeted Treatment, New A
March 01, 2013
from
GlobeNewswire News Releases
NASDAQ Gainers Watch List: NetSol Technologies, Inc. (NASDAQ:NTWK) and Endocyte, Inc. (NASDAQ:ECYT) Added to Growing Stock Report's NASDAQ Gainers Watch List.
February 28, 2013
New York, NY -- (SBWIRE) -- 02/28/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding NetSol Technologies, Inc. (NASDAQ:NTWK) and Endocyte, Inc. (NASDAQ:ECYT)
Read More
from
SBWire - Latest Press Releases
Endocyte to Present at Upcoming Conferences in March
February 26, 2013
from
GlobeNewswire News Releases
(MAA) Revenues Rise at Endocyte
February 26, 2013
Endocyte, Inc. (ECYT) reported fourth quarter 2012 net loss per share of 2 cents, in line with the... Visit StockBlogHub to view complete post.
Read More
category
REIT / Residential
,
Lannett Company Inc
,
UTHR
, and 9 more.
from
Stock Blog Hub
Endocyte, Inc. (ECYT) Reports In-Line Q4 Loss of 2c/Share
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8129668 for the full story.
Read More
from
StreetInsider.com News Articles
Endocyte Reports Fourth Quarter and Year End 2012 Financial Results and Business Update
February 25, 2013
from
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.